These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4949239)

  • 21. Sepharose gel filtration method of purification of lipopolysaccharides.
    Romanowska E
    Anal Biochem; 1970 Feb; 33(2):383-9. PubMed ID: 4909226
    [No Abstract]   [Full Text] [Related]  

  • 22. The identification of 2-amino-2-deoxy-L-altruronic acid as a constituent of Shigella sonnei phase I lipopolysaccharide.
    Kontrohr T
    Carbohydr Res; 1977 Oct; 58(2):498-500. PubMed ID: 334368
    [No Abstract]   [Full Text] [Related]  

  • 23. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antigenic composition of different forms of Sh. sonnei].
    Vaneeva NP; Khomenko NA; Tsvetkova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):49-53. PubMed ID: 60855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The purification of the peptidoglycan associated protein of Shigella sonnei phase I by chromatofocusing.
    Adamus G; Romanowska E
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):489-92. PubMed ID: 6398686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological and chemical studies of Sh. sonnei, Pseudomonas shigelloides and C27 strains.
    Rauss K; Kontrohr T; Vertényi A; Szendrei L
    Acta Microbiol Acad Sci Hung; 1970; 17(2):157-66. PubMed ID: 4992458
    [No Abstract]   [Full Text] [Related]  

  • 27. [Features of the monosaccharide composition and ultrastructure of lipopolysaccharides of different forms of Shigella sonnei].
    Vaneeva NP; Tsvetkova NV; Khomenko NA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Jun; (6):69-73. PubMed ID: 331785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Citrate method of extracting antigens from Shigella sonnei. I. Comparison with other methods].
    Kamzolkina NB; Iarovaia LM
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Feb; (2):72-7. PubMed ID: 6166136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances.
    Munoz C; Baqar S; van de Verg L; Thupari J; Goldblum S; Olson JG; Taylor DN; Heresi GP; Murphy JR
    Am J Trop Med Hyg; 1995 Jul; 53(1):47-54. PubMed ID: 7542845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outer membrane proteins of Shigella sonnei. I. Characterization of phase I, phase II and R-form Shigella sonnei.
    Adamus G; Romanowska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):547-52. PubMed ID: 7006562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of the specific activity and chemical composition of various tuberculoprotein fractions].
    Lazovskaia AL; Golubeva SA
    Probl Tuberk; 1970; 48(10):58-61. PubMed ID: 4993150
    [No Abstract]   [Full Text] [Related]  

  • 33. [Theoretical conformation analysis of specific O-antigenic polysaccharides. Polysaccharide of Shigella dysenteriae of serotype 2].
    Lipkind GM; Kochetkov NK
    Bioorg Khim; 1983 Nov; 9(11):1568-77. PubMed ID: 6207841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antigenic and tolerogenic properties of Shigella sonnei lipopolysaccharide].
    Borisov VA; Gofman IL
    Mikrobiol Zh (1978); 1981; 43(1):74-7. PubMed ID: 7019631
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nonspecific nature of antibody formation suppression by virulent Shigella sonnei].
    Borisov VA; Frolov AF
    Mikrobiol Zh (1978); 1982; 44(1):71-6. PubMed ID: 7040918
    [No Abstract]   [Full Text] [Related]  

  • 36. [Detection of the host specificity system in shigellae].
    Tediashvili MI; Uporova TM; Nikol'skaia II; Debov SS
    Biull Eksp Biol Med; 1980 Sep; 90(9):324-5. PubMed ID: 7000200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preparation of colicin produced by Shigella sonnei 100052].
    Matsuguchi M; Taniya K; Amako K
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):95. PubMed ID: 765575
    [No Abstract]   [Full Text] [Related]  

  • 38. [Irradiation sterilization of Shigella sonnei antigens].
    Thilo W; Butte H; Koch W; Weister A
    Z Gesamte Hyg; 1971 Aug; 17(8):615-7. PubMed ID: 4945565
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental model of high-dosage immunological tolerance to Shigella sonnei lipopolysaccharide].
    Borisov VA; Gofman IL
    Mikrobiol Zh (1978); 1980; 42(6):723-6. PubMed ID: 7007829
    [No Abstract]   [Full Text] [Related]  

  • 40. A bacteriocin induced from a strain of Shigella sonnei.
    Amako K; Tokiwa H; Takeya K
    Jpn J Microbiol; 1970 Nov; 14(6):505-7. PubMed ID: 4922342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.